Jonathan Zalevsky

Chief R&D Officer

Chief R&D Officer at NEKTAR THERAPEUTICS, filing insider transactions on 2026-08-18.

Total Purchases

—

0 transactions

Total Sales

$13K

1 transaction

Companies Traded

1

1 total filings

Active Since

2026-08-18

Last: 2026-08-18

Companies

NEKTAR THERAPEUTICS

Other Reporting Insiders at Nektar Therapeutics

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-18	NKTR	Sale	186	$71.98	$13K	9,570	SEC ↗

Jonathan Zalevsky (Nektar Therapeutics) Insider Trades | Tormere